readers respond

Maddy, Paul; Brumble, Sharon; Fisher, J.
July 2005
PN;Jul2005, Vol. 59 Issue 7, p12
Trade Publication
Presents letters to the editor related to articles and issues, published in different editions of the journal "Paraplegia News." Information on stem-cell research; Reference to the article "Cathing Alternative," published in the March 2005 issue; Appreciation of the journal by a veteran having multiple sclerosis.


Related Articles

  • inbox. Kish, Carrie; Olszyk, Steve; Taylor, Lynn; Weigle, Pat; Daetsch, Rosemary; Searfoss, Kristin; Hall, Tana; Hicks, Ursula; Chesley, Stephanie; McCagg, Todd // Inside MS;Aug/Sep2006, Vol. 24 Issue 4, p13 

    Several letters to the editor are presented in response to articles in the April-May 2006 issue including "How I Cope With Progressive MS," by Julia Graham, "Clay Walker Talking" and "Living With an MS Bladder."

  • Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mancardi, Giovanni Luigi; Murialdo, Alessandra; Rossi, Paolo; Gualandi, Francesca; Martino, Gianvito; Marmont, Alberto; Ciceri, Fabio; Schenone, Angelo; Parodi, Roberto Carlo; Capello, Elisabetta; Comi, Giancarlo; Uccelli, Antonio // Multiple Sclerosis (13524585);Jun2005, Vol. 11 Issue 3, p367 

    Malignant forms of multiple sclerosis (MS) represent a limited group of very aggressive demyelinating diseases, which rapidly progress to severe disability leading often to life-threatening conditions. On these clinical entities, currently available therapies for MS are not very effective....

  • Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells. Rivera, Francisco J.; Kraus, J�rg; Steffenhagen, Carolin; K�ry, Patrick; Weidner, Norbert; Aigner, Ludwig // Current Signal Transduction Therapy;Sep2011, Vol. 6 Issue 3, p293 

    Multiple sclerosis (MS) is a demyelinating immune-mediated disease of the central nervous system (CNS). It is the most common cause of acquired disability in young adults and affects over 2 Mio people worldwide. Current treatments target primarily the immune system, reduce the relapse rate and...

  • Insight into Multiple Sclerosis. Wehman-Tubbs, Kelli; Yale, Steven H.; Rolak, Loren A. // Clinical Medicine & Research;Feb2005, Vol. 3 Issue 1, p41 

    Presents information on multiple sclerosis. Knowledge of the pathogenesis of multiple sclerosis; Definition of the most common presentation for patients with multiple sclerosis; Tests available to assist in the diagnosis of multiple sclerosis.

  • The Lesions of Multiple Sclerosis. Paty, Donald W.; Arnold, Douglas L. // New England Journal of Medicine;1/17/2002, Vol. 346 Issue 3, p199 

    Editorial. Discusses multiple sclerosis (MS). Reference to reports by Chang and colleagues and by Brex et al in this issue; How the findings are important to an understanding of the remyelination of lesions of MS and imply that transplantation of oligodendrocyte precursor cells will probably not...

  • American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study. Kim, E; Cameron, M; Lovera, J; Schaben, L; Bourdette, D; Whitham, R // Multiple Sclerosis Journal;Dec2011, Vol. 17 Issue 12, p1523 

    This study examined the safety and efficacy of an escalating dose (100?mg, 200?mg, 400?mg/day) of American ginseng over 6 weeks in a single-center, randomized, double-blind, placebo-controlled, crossover trial with 56 subjects with multiple sclerosis and fatigue. There were no serious adverse...

  • New Research, Hope for MS Patients. V.D. // Access;Nov2001, Vol. 15 Issue 9, p10 

    Reports on various avenues of medical research explored in managing patients with multiple sclerosis. Possible connection of hormones in the recovery of women with multiple sclerosis; Process of degeneration of the myelin sheath of the central nervous system resulting from multiple sclerosis;...

  • Epidemiology of Multiple Sclerosis in Western Herzegovina and Herzegovina -- Neretva Canton, Bosnia and Herzegovina. Klupka-Sarić, Inge; Galić, Marijana // Collegium Antropologicum;2010 Supplement 1, Vol. 34, p189 

    The aim of this study was to investigate the selected indicators of multiple sclerosis (MS) in Herzegovina (Western Herzegovina Canton and Herzegovina-Neretva Canton). By using all available health and medical sources in the studied area and using McDonald's criteria, a total of 96 patients were...

  • Defining the natural history of MS: the need for complete data and rigorous definitions. Confavreux, C. // Multiple Sclerosis (13524585);Apr2008, Vol. 14 Issue 3, p289 

    The article reports on the study regarding secondary progressive multiple sclerosis (SPMS) in British Columbia. It found that the median time from an exacerbating-remitting onset of MS to conversion to secondary progression could be estimated using the Kaplan-Meier technique. It also shows that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics